137 results
Page 2 of 7
20-F/A
uz9lbmkysnkib lnq
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
2mueq 7qal7
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.5
e6cso5wjf48d1nmz8
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
8dgol
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
a2gyf d3iw
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
cxxaj9a5weoqp4ve
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
hx9lolzfluhhjkdha
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
cybbqaijreu9m98qhz
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.2
nsqkfqib9y1vdtl4
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.3
0povoiwmuw1ifx9xd1t
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.1
94rz 6qm2irbfgv9r
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
z0jnkmzrsh w54hicq3
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
y2zt53e8
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
efrw4
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.1
xm5h8pypbslxi
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
v2cl1c41h
23 Jan 19
51-102F3 Material Change Report
12:44pm